PubMed:12809821 / 0-416
Annnotations
DisGeNET
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T0 | 32-36 | gene:1555 | denotes | p450 |
| T1 | 50-69 | disease:C0374997 | denotes | Helicobacter pylori |
| R1 | T0 | T1 | associated_with | p450,Helicobacter pylori |
DisGeNET5_gene_disease
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 12809821-0#32#36#gene1555 | 32-36 | gene1555 | denotes | p450 |
| 12809821-0#50#69#diseaseC0374997 | 50-69 | diseaseC0374997 | denotes | Helicobacter pylori |
| 32#36#gene155550#69#diseaseC0374997 | 12809821-0#32#36#gene1555 | 12809821-0#50#69#diseaseC0374997 | associated_with | p450,Helicobacter pylori |
PubMed_Structured_Abstracts
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 93-253 | OBJECTIVE | denotes | The aim of this pharmacogenomics study was to investigate the influence of different cytochrome P450 (CYP) genotypes in Helicobacter pylori eradication therapy. |